TY - CHAP M1 - Book, Section TI - Heart Disease in Pregnancy A1 - Halpern, Dan G. A1 - Sarma, Amy A1 - Economy, Katherine E. A1 - Valente, Anne Marie A2 - Fuster, Valentin A2 - Narula, Jagat A2 - Vaishnava, Prashant A2 - Leon, Martin B. A2 - Callans, David J. A2 - Rumsfeld, John S. A2 - Poppas, Athena PY - 2022 T2 - Fuster and Hurst's The Heart, 15e AB - Chapter SummaryCardiovascular disease (CVD) complicates 1% to 4% of pregnancies and is the primary cause of nonobstetric maternal mortality. Older maternal age, with associated increases in CVD risk factors such as obesity, hypertension, and diabetes, as well as improved survival of patients with congenital heart disease have increased the burden of CVD during pregnancy. Optimal patient care for the pregnant woman with CVD relies on an understanding of the unique hemodynamic changes of pregnancy and the pathophysiology, signs and symptoms, and natural history specific to each heart condition that may impact pregnancy. Preconception consultation of pregnant women with CVD is imperative and such individuals should be cared for by expert multidisciplinary teams in anticipation of possible complications that may arise during the antepartum, intrapartum, and postpartum periods. Pregnancy is not advised in several conditions and some medications are contraindicated during pregnancy (see Fuster and Hurst’s Central Illustration). SN - PB - McGraw-Hill Education CY - New York, NY Y2 - 2024/03/29 UR - accessmedicine.mhmedical.com/content.aspx?aid=1202453624 ER -